Signaturefd LLC Decreases Holdings in Xylem Inc. (NYSE:XYL)

Signaturefd LLC trimmed its stake in shares of Xylem Inc. (NYSE:XYL) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,311 shares of the industrial products company’s stock after selling 110 shares during the period. Signaturefd LLC’s holdings in Xylem were worth $493,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Kornitzer Capital Management Inc. KS lifted its holdings in Xylem by 9.0% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 109,882 shares of the industrial products company’s stock valued at $12,566,000 after purchasing an additional 9,114 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Xylem by 10,296.7% during the fourth quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock valued at $7,205,000 after purchasing an additional 62,398 shares in the last quarter. ING Groep NV purchased a new position in Xylem during the third quarter valued at $2,752,000. Meiji Yasuda Asset Management Co Ltd. lifted its stake in shares of Xylem by 6.6% in the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 39,266 shares of the industrial products company’s stock worth $3,574,000 after buying an additional 2,438 shares in the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of Xylem by 351.2% in the fourth quarter. SG Americas Securities LLC now owns 101,408 shares of the industrial products company’s stock worth $11,597,000 after buying an additional 78,934 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

Xylem stock opened at $130.67 on Thursday. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $132.23. The stock has a market cap of $31.67 billion, a P/E ratio of 48.04, a PEG ratio of 2.60 and a beta of 1.10. The company has a 50-day moving average price of $127.30 and a 200 day moving average price of $113.22. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The firm had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.05 billion. During the same period last year, the business earned $0.92 earnings per share. Xylem’s revenue was up 40.6% compared to the same quarter last year. Sell-side analysts anticipate that Xylem Inc. will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, February 20th. This is a boost from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.10%. Xylem’s dividend payout ratio (DPR) is currently 52.94%.

Insider Buying and Selling at Xylem

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

XYL has been the topic of several research reports. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. BNP Paribas initiated coverage on shares of Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price target on the stock. Royal Bank of Canada raised their price target on shares of Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 7th. Citigroup raised their price target on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Finally, Stifel Nicolaus raised their price target on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $138.11.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.